Higher topoisomerase 2 alpha gene transcript levels predict better prognosis in GBM patients receiving temozolomide chemotherapy: identification of temozolomide as a TOP2A inhibitor.
Saved in:
| Title: | Higher topoisomerase 2 alpha gene transcript levels predict better prognosis in GBM patients receiving temozolomide chemotherapy: identification of temozolomide as a TOP2A inhibitor. |
|---|---|
| Authors: | Arivazhagan A; Department of Neurosurgery, National Institute of Mental Health and Neuro Sciences, Bangalore 560029, India., Kumar DM, Sagar V, Patric IR, Sridevi S, Thota B, Srividya MR, Prasanna K, Thennarasu K, Mondal N, Hegde AS, Chandramouli BA, Santosh V, Rao MR, Kondaiah P, Somasundaram K |
| Source: | Journal of neuro-oncology [J Neurooncol] 2012 Apr; Vol. 107 (2), pp. 289-97. Date of Electronic Publication: 2011 Nov 19. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Springer Country of Publication: United States NLM ID: 8309335 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7373 (Electronic) Linking ISSN: 0167594X NLM ISO Abbreviation: J Neurooncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 22102081 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Higher topoisomerase 2 alpha gene transcript levels predict better prognosis in GBM patients receiving temozolomide chemotherapy: identification of temozolomide as a TOP2A inhibitor. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Arivazhagan+A%22">Arivazhagan A</searchLink>; Department of Neurosurgery, National Institute of Mental Health and Neuro Sciences, Bangalore 560029, India.<br /><searchLink fieldCode="AU" term="%22Kumar+DM%22">Kumar DM</searchLink><br /><searchLink fieldCode="AU" term="%22Sagar+V%22">Sagar V</searchLink><br /><searchLink fieldCode="AU" term="%22Patric+IR%22">Patric IR</searchLink><br /><searchLink fieldCode="AU" term="%22Sridevi+S%22">Sridevi S</searchLink><br /><searchLink fieldCode="AU" term="%22Thota+B%22">Thota B</searchLink><br /><searchLink fieldCode="AU" term="%22Srividya+MR%22">Srividya MR</searchLink><br /><searchLink fieldCode="AU" term="%22Prasanna+K%22">Prasanna K</searchLink><br /><searchLink fieldCode="AU" term="%22Thennarasu+K%22">Thennarasu K</searchLink><br /><searchLink fieldCode="AU" term="%22Mondal+N%22">Mondal N</searchLink><br /><searchLink fieldCode="AU" term="%22Hegde+AS%22">Hegde AS</searchLink><br /><searchLink fieldCode="AU" term="%22Chandramouli+BA%22">Chandramouli BA</searchLink><br /><searchLink fieldCode="AU" term="%22Santosh+V%22">Santosh V</searchLink><br /><searchLink fieldCode="AU" term="%22Rao+MR%22">Rao MR</searchLink><br /><searchLink fieldCode="AU" term="%22Kondaiah+P%22">Kondaiah P</searchLink><br /><searchLink fieldCode="AU" term="%22Somasundaram+K%22">Somasundaram K</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228309335%22">Journal of neuro-oncology</searchLink> [J Neurooncol] 2012 Apr; Vol. 107 (2), pp. 289-97. <i>Date of Electronic Publication: </i>2011 Nov 19. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer%22">Springer </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8309335 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1573-7373 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220167594X%22">0167594X </searchLink><i>NLM ISO Abbreviation: </i>J Neurooncol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=22102081 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s11060-011-0758-3 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 289 Titles: – TitleFull: Higher topoisomerase 2 alpha gene transcript levels predict better prognosis in GBM patients receiving temozolomide chemotherapy: identification of temozolomide as a TOP2A inhibitor. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Arivazhagan A – PersonEntity: Name: NameFull: Kumar DM – PersonEntity: Name: NameFull: Sagar V – PersonEntity: Name: NameFull: Patric IR – PersonEntity: Name: NameFull: Sridevi S – PersonEntity: Name: NameFull: Thota B – PersonEntity: Name: NameFull: Srividya MR – PersonEntity: Name: NameFull: Prasanna K – PersonEntity: Name: NameFull: Thennarasu K – PersonEntity: Name: NameFull: Mondal N – PersonEntity: Name: NameFull: Hegde AS – PersonEntity: Name: NameFull: Chandramouli BA – PersonEntity: Name: NameFull: Santosh V – PersonEntity: Name: NameFull: Rao MR – PersonEntity: Name: NameFull: Kondaiah P – PersonEntity: Name: NameFull: Somasundaram K IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 04 Text: 2012 Apr Type: published Y: 2012 Identifiers: – Type: issn-electronic Value: 1573-7373 Numbering: – Type: volume Value: 107 – Type: issue Value: 2 Titles: – TitleFull: Journal of neuro-oncology Type: main |
| ResultId | 1 |
